Low expression of AGER was significantly correlated with histology, stage, lymph node metastasis, and tumor protein 53 (TP53) mutation and could be used as a potential indicator of poor prognosis of LUAD and LUSC. The gene discussed is AGER; the disease is metastatic malignant neoplasm in the lymph nodes.